Delivery of Entire Bioactive Mitochondria with Metal Organic Framework for Cancer Research and Therapy

Description of the granted funding

Mitochondria (Mit) are the power station of cells and Mit´s disorder plays a significant role in cancer. Several Mit targeting therapies have been investigated and shown promise in cancer treatment. Here, the entire bioactive Mit delivery has been enabled by encapsulating Mit in metal organic framework, which can very well maintain their bioactivity, enhance the intracellular delivery efficiency, and enable the in vivo administration. Due to the dynamic nature of Mit, the continuous delivering of entire bioactive Mit isolated from healthy cells to cancer cells will gradually replace the disordered Mit by fusion and division in cells. The Mit induced behavior changes in cancer cells will greatly improve the understanding of Mit´s roles in cancer therapy and the possible roles in reprograming of the cancer cells back to healthy cells. This method is milestone for whole Mit research field and may generate breakthrough in treating all kinds of Mit related diseases.
Show more

Starting year

2022

End year

2026

Granted funding

Hongbo Zhang Orcid -palvelun logo
474 144 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Other information

Funding decision number

347897

Fields of science

Pharmacy

Research fields

Farmasia

Themes

Nuori tutkijasukupolvi 2021

Identified topics

cancer